Alambic Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-18,355
Closed -$310K 312
2018
Q2
$310K Sell
18,355
-196,532
-91% -$3.72M 0.08% 265
2018
Q1
$4.21M Buy
214,887
+158,114
+279% +$3.06M 0.59% 31
2017
Q4
$1.15M Buy
56,773
+14,200
+33% +$261K 0.14% 237
2017
Q3
$739K Buy
42,573
+11,300
+36% +$153K 0.08% 308
2017
Q2
$401K Buy
31,273
+1,200
+4% +$16K 0.05% 416
2017
Q1
$390K Buy
30,073
+12,500
+71% +$158K 0.05% 454
2016
Q4
$174K Hold
17,573
0.03% 514
2016
Q3
$212K Sell
17,573
-1,400
-7% -$14.3K 0.05% 422
2016
Q2
$164K Sell
18,973
-30,600
-62% -$302K 0.04% 473
2016
Q1
$469K Buy
49,573
+14,173
+40% +$133K 0.15% 228
2015
Q4
$613K Buy
+35,400
New +$564K 0.37% 96

Other funds holding HALO

Alambic Investment Management's HALO Position: Q3 2018 in Review

Alambic Investment Management sold out of Halozyme (HALO) in Q3 2018, closing a stake of 18,355 shares — an estimated $310K sold.

Alambic Investment Management first reported a position in HALO in Q4 2015 and held it in 11 quarters. The position peaked at $4.21M in Q1 2018. 193 funds tracked by Wall St. Rank hold HALO as of Q3 2018.

  • Alambic Investment Management reported no remaining Halozyme position as of Q3 2018 after selling out during the quarter.
  • Alambic Investment Management sold 18,355 Halozyme shares in Q3 2018, an estimated $310K.
  • Alambic Investment Management first reported a position in Halozyme in Q4 2015 and held it in 11 quarters.
  • Alambic Investment Management's Halozyme position peaked at $4.21M in Q1 2018.
  • 193 funds tracked by Wall St. Rank held Halozyme as of Q3 2018.

Based on Alambic Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.